Sentus
Payments companies reported to CMS as associated with Sentus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Sentus, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Sentus
These are the largest totals companies reported as associated with Sentus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Marrick Kukin | New York, NY | Cardiovascular Disease | $15,115.00 |
| James Heywood | La Jolla, CA | Advanced Heart Failure and Transplant Cardiology | $12,400.00 |
| Emil Missov | Greenville, NC | Advanced Heart Failure and Transplant Cardiology | $7,200.00 |
| Emad Aziz | Newark, NJ | Clinical Cardiac Electrophysiology | $6,600.00 |
| Roderick Tung | Chicago, IL | Clinical Cardiac Electrophysiology | $2,891.82 |
| Kalyanam Shivkumar | Los Angeles, CA | Cardiovascular Disease | $1,909.72 |
| Mena Yacoub | Roslyn, NY | Clinical Cardiac Electrophysiology | $1,594.06 |
| Binaya Basyal | Richmond, VA | Clinical Cardiac Electrophysiology | $1,456.82 |
| Jakrin Kewcharoen | Honolulu, HI | $1,414.80 | |
| Asad Mohammad | New York, NY | Clinical Cardiac Electrophysiology | $1,301.56 |
Prescribed Sentus?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.